Ultragenyx Pharmaceutical RARE

$ 24.53 2.25%

Quarterly report 2025-Q3
added 04-18-2026

Ultragenyx Pharmaceutical Total Inventories 2011-2026 | RARE

Annual Total Inventories Ultragenyx Pharmaceutical

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
52 M	45 M	34 M	26.8 M	16.2 M	13 M	11.5 M	7.06 M	757 K	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
52 M	757 K	22.9 M

Quarterly Total Inventories Ultragenyx Pharmaceutical

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
52.2 M	46.5 M	46 M	45 M	43.3 M	40.1 M	35.9 M	34 M	31.8 M	28.3 M	26.6 M	26.8 M	21.8 M	21.1 M	17.8 M	16.2 M	15.2 M	15.1 M	12.5 M	13 M	14.5 M	11.1 M	11.4 M	11.5 M	11.5 M	11.5 M	11.5 M	7.06 M	7.06 M	7.06 M	7.06 M	757 K	757 K	757 K	757 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
52.2 M	757 K	20.1 M

Total Inventories of other stocks in the Biotechnology industry

	Issuer	Total Inventories	Price	% 24h	Market Cap	Country
	Aptorum Group Limited APM	39.1 K	$ 0.88	-2.07 %	$ 6.47 M	China
	ACADIA Pharmaceuticals ACAD	91.7 M	$ 22.67	1.66 %	$ 3.76 B	USA
	BioDelivery Sciences International BDSI	23.7 M	-	-4.8 %	$ 255 M	USA
	Aquestive Therapeutics AQST	6.17 M	$ 4.09	-0.24 %	$ 437 M	USA
	Arcutis Biotherapeutics ARQT	22.6 M	$ 23.29	-0.56 %	$ 2.96 B	USA
	Autolus Therapeutics plc AUTL	33.2 M	$ 1.48	4.23 %	$ 394 M	Britain
	BeiGene, Ltd. BGNE	608 M	-	0.49 %	$ 251 B	Cayman-islands
	bluebird bio BLUE	22.9 M	-	-	$ 546 M	USA
	Cara Therapeutics CARA	2.82 M	-	-3.03 %	$ 260 M	USA
	CASI Pharmaceuticals CASI	1.91 M	-	-	$ 35.4 M	USA
	BioXcel Therapeutics BTAI	722 K	$ 1.06	-2.75 %	$ 12.9 M	USA
	ChemoCentryx CCXI	851 K	-	-	$ 3.74 B	USA